Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-18 8:37 pm Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | Tarriff Scott | 2,470,570 17.6% | -62,887 (-2.48%) | View |
| 2024-02-14 5:09 pm Purchase | 13D | EAGLE PHARMACEUTICALS INC EGRX | Graves Michael | 238,660 1.8% | 238,660 (New Position) | View |
| 2024-02-13 5:04 pm Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | VANGUARD GROUP INC | 638,124 4.91% | -125,683 (-16.45%) | View |
| 2024-02-13 3:53 pm Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | JANUS HENDERSON GROUP PLC JHG | 775,525 6% | -454,347 (-36.94%) | View |
| 2024-02-12 1:38 pm Purchase | 13G | EAGLE PHARMACEUTICALS INC EGRX | BRANDES INVESTMENT PARTNERS LP | 745,079 5.74% | 745,079 (New Position) | View |
| 2024-02-07 09:15 am Purchase | 13G | EAGLE PHARMACEUTICALS INC EGRX | HIRSCHMAN ORIN | 1,061,509 8.2% | 1,061,509 (New Position) | View |
| 2024-01-26 11:49 am Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | BlackRock Inc. BLK | 984,075 7.6% | -25,015 (-2.48%) | View |
| 2024-01-22 2:04 pm Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | STATE STREET CORP STT | 222,594 1.71% | -729,432 (-76.62%) | View |
| 2023-07-07 4:35 pm Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | BlackRock Inc. BLK | 1,009,090 7.7% | -863,811 (-46.12%) | View |
| 2023-02-14 4:34 pm Purchase | 13G | EAGLE PHARMACEUTICALS INC EGRX | Tarriff Scott | 2,533,457 18.06% | 113,483 (+4.69%) | View |
| 2023-02-13 09:26 am Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | JANUS HENDERSON GROUP PLC JHG | 1,229,872 9.4% | -298,280 (-19.52%) | View |
| 2023-02-09 11:16 am Purchase | 13G | EAGLE PHARMACEUTICALS INC EGRX | VANGUARD GROUP INC | 763,807 5.87% | 3,339 (+0.44%) | View |
| 2023-02-03 4:08 pm Purchase | 13G | EAGLE PHARMACEUTICALS INC EGRX | STATE STREET CORP STT | 952,026 7.31% | 243,802 (+34.42%) | View |
| 2023-01-26 08:52 am Unchanged | 13G | EAGLE PHARMACEUTICALS INC EGRX | BlackRock Inc. BLK | 1,872,901 14.4% | 0 (Unchanged) | View |
| 2023-01-20 3:00 pm Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | BlackRock Inc. BLK | 1,872,901 14.4% | -95,915 (-4.87%) | View |
| 2022-02-14 4:13 pm Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | Park West Asset Management LLC | 0 0% | -791,600 (Position Closed) | View |
| 2022-02-14 4:00 pm Purchase | 13G | EAGLE PHARMACEUTICALS INC EGRX | Tarriff Scott | 2,419,974 17.61% | 99,355 (+4.28%) | View |
| 2022-02-11 09:41 am Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | STATE STREET CORP STT | 708,224 5.48% | -105,877 (-13.01%) | View |
| 2022-02-10 6:01 pm Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | JANUS HENDERSON GROUP PLC JHG | 1,528,152 11.8% | -165,921 (-9.79%) | View |
| 2022-02-09 3:43 pm Sale | 13G | EAGLE PHARMACEUTICALS INC EGRX | VANGUARD GROUP INC | 760,468 5.89% | -4,467 (-0.58%) | View |